Literature DB >> 21220401

Recurrent fever syndromes in patients after recovery from Kawasaki syndrome.

Lori Broderick1, Adriana H Tremoulet, Jane C Burns, John F Bastian, Hal M Hoffman.   

Abstract

The recurrence of fever in a child with a history of Kawasaki syndrome (KS) poses a dilemma for clinicians who must consider the possibility of recurrent KS. In this report we present the cases of 4 patients who presented with classical symptoms of KS, were successfully treated with intravenous immunoglobulin, and later experienced a reappearance of inflammatory symptoms in a pattern consistent with a recurrent fever syndrome. The association of these syndromes within the same patient suggests that some patients may have a genetic propensity toward altered immune responses and autoinflammatory syndromes. We propose that these 2 syndromes exist within a family of febrile disorders related to innate immune dysregulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220401      PMCID: PMC3025426          DOI: 10.1542/peds.2010-1218

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

Review 1.  Incomplete (atypical) Kawasaki disease.

Authors:  Anne H Rowley
Journal:  Pediatr Infect Dis J       Date:  2002-06       Impact factor: 2.129

Review 2.  Recurrent febrile syndromes: what a rheumatologist needs to know.

Authors:  Hal M Hoffman; Anna Simon
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

3.  Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production.

Authors:  K C Bhol; A Desai; S Kumari; J E Colon; A R Ahmed
Journal:  Clin Immunol       Date:  2001-08       Impact factor: 3.969

Review 4.  Kawasaki disease: update on pathogenesis.

Authors:  Rae S M Yeung
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

5.  Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan.

Authors:  S Hirata; Y Nakamura; H Yanagawa
Journal:  Acta Paediatr       Date:  2001-01       Impact factor: 2.299

6.  Clinical features of atypical Kawasaki disease.

Authors:  Y C Hsieh; M H Wu; J K Wang; P I Lee; C Y Lee; L M Huang
Journal:  J Microbiol Immunol Infect       Date:  2002-03       Impact factor: 4.399

7.  Psoriatic eruption in Kawasaki disease.

Authors:  B A Eberhard; R P Sundel; J W Newburger; A Baker; R C Fuhlbrigge; J C Burns; S E Gellis
Journal:  J Pediatr       Date:  2000-10       Impact factor: 4.406

Review 8.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 9.  Auto-inflammatory syndromes and oral health.

Authors:  C Scully; T Hodgson; H Lachmann
Journal:  Oral Dis       Date:  2008-11       Impact factor: 3.511

Review 10.  Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*).

Authors:  Seth L Masters; Anna Simon; Ivona Aksentijevich; Daniel L Kastner
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more
  7 in total

Review 1.  Autoinflammatory Disease-Associated Vasculitis/Vasculopathy.

Authors:  Mansour Alghamdi
Journal:  Curr Rheumatol Rep       Date:  2018-11-17       Impact factor: 4.592

Review 2.  IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting.

Authors:  Lori Broderick; Hal M Hoffman
Journal:  Nat Rev Rheumatol       Date:  2022-06-21       Impact factor: 32.286

Review 3.  A four-time-recurring typical complete Kawasaki syndrome successfully treated with intravenous immunoglobulin: a case report with literature review.

Authors:  Fernanda Falcini; Grazia D'Adamo; Donato Rigante
Journal:  Rheumatol Int       Date:  2012-07-20       Impact factor: 3.580

4.  Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report.

Authors:  Suhas M Radhakrishna; Amy Grimm; Lori Broderick
Journal:  BMC Pediatr       Date:  2017-04-20       Impact factor: 2.125

5.  Using the Electronic Medical Record to Correlate Kawasaki Disease Phenotypes With Clinical Outcomes.

Authors:  Preeti Jaggi; Michelle Grcic; John Kovalchin; Carolyn M Wilhelm; Cagri Yildirim-Toruner; Karen Texter
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-15       Impact factor: 3.164

Review 6.  Kawasaki disease: a matter of innate immunity.

Authors:  T Hara; Y Nakashima; Y Sakai; H Nishio; Y Motomura; S Yamasaki
Journal:  Clin Exp Immunol       Date:  2016-08-03       Impact factor: 4.330

Review 7.  Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.

Authors:  Bin Tang; Hang Hong Lo; Cheng Lei; Ka In U; Wen-Luan Wendy Hsiao; Xiaoling Guo; Jun Bai; Vincent Kam-Wai Wong; Betty Yuen-Kwan Law
Journal:  Phytomedicine       Date:  2020-03-18       Impact factor: 5.340

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.